Study Title

68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer (PSMA)

Study Details

Description:

This is a phase II clinical trial study to show how well the 68Ga-PSMA-11 (ProstaMedix™) PET-CT scan works in detecting tumor location and size in patients with suspected or confirmed prostate cancer, as well as prostate cancer that may have come back in patients with elevated PSA ( a prostate-specific antigen tumor marker) after initial treatment.

Sponsor:

RadioMedix

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468